2005
DOI: 10.1016/j.ophtha.2004.12.007
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Intraepithelial Neoplasia Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Under this regimen, healing was observed within 3 months. IFN2B was well tolerated, with only localised and mild conjunctival hyperaemia being observed 2. No recurrence was detectable more than 2 years following IFN2B treatment.…”
Section: Case Reportmentioning
confidence: 84%
“…Under this regimen, healing was observed within 3 months. IFN2B was well tolerated, with only localised and mild conjunctival hyperaemia being observed 2. No recurrence was detectable more than 2 years following IFN2B treatment.…”
Section: Case Reportmentioning
confidence: 84%
“…In general, it seems that the disadvantage with topical treatment is the long duration. We must emphasize the importance of long term follow-up for CIN patients because recurrences can occur anywhere from 33 days to 11.5 years (Tabin et al, 1997), although most recurrent CIN occurs within 2 years of initial excision (Schechter et al, 2005).…”
Section: Interferon (Inf) Alpha 2bmentioning
confidence: 99%